Fadrowski Jeffrey J, Frankenfield Diane L, Friedman Aaron L, Warady Bradley A, Neu Alicia M, Fivush Barbara A
Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Am J Kidney Dis. 2006 Jan;47(1):115-21. doi: 10.1053/j.ajkd.2005.10.005.
Children with end-stage renal disease (ESRD) receiving hemodialysis may have their care overseen primarily by a pediatric nephrologist or internal medicine (IM) nephrologist.
To examine specific clinical outcomes by nephrologist specialization, a cross-sectional analysis of demographic and clinical data collected in the 2002 ESRD Clinical Performance Measures Project was performed.
Of 653 pediatric patients meeting inclusion criteria, 27% were cared for by IM nephrologists, and 73%, by pediatric nephrologists. Pediatric nephrologists were significantly more likely than IM nephrologists to care for patients who were younger and of Hispanic ethnicity. Patients of pediatric compared with IM nephrologists also were more likely to have a congenital cause of ESRD, smaller body mass index, and longer time on dialysis therapy. No significant differences in achieving a mean Kt/V of 1.2 or greater or mean hemoglobin level of 11 g/dL or greater (> or =110 g/L) according to nephrologist specialization were observed. After adjustment for patient clinical characteristics, no significant difference in use of arteriovenous fistulae was observed. Patients cared for by pediatric nephrologists were less likely to achieve a mean serum albumin level of 4.0/3.7 g/dL (40/37 g/L; bromcresol green laboratory method/bromcresol purple laboratory method; adjusted odds ratio, 0.60; 95% confidence interval, 0.42 to 0.86). Patients cared for by pediatric nephrologists had significantly greater serum calcium levels, lower serum phosphate levels, and lower intact parathyroid hormone levels.
Using adult-focused clinical care targets, care provided by pediatric and IM nephrologists to pediatric patients receiving hemodialysis in the United States is similar. However, differences exist, and the significance of these differences requires further study.
接受血液透析的终末期肾病(ESRD)儿童可能主要由儿科肾病专家或内科(IM)肾病专家负责护理。
为了通过肾病专家的专业领域来检查特定的临床结果,对2002年ESRD临床绩效评估项目中收集的人口统计学和临床数据进行了横断面分析。
在653名符合纳入标准的儿科患者中,27%由IM肾病专家护理,73%由儿科肾病专家护理。儿科肾病专家比IM肾病专家更有可能护理年龄较小且为西班牙裔的患者。与IM肾病专家护理的患者相比,儿科肾病专家护理的患者也更有可能因先天性原因导致ESRD、体重指数较小且透析治疗时间更长。根据肾病专家的专业领域,在平均Kt/V达到1.2或更高或平均血红蛋白水平达到11 g/dL或更高(≥110 g/L)方面未观察到显著差异。在对患者临床特征进行调整后,在动静脉内瘘的使用方面未观察到显著差异。由儿科肾病专家护理的患者不太可能达到平均血清白蛋白水平4.0/3.7 g/dL(40/37 g/L;溴甲酚绿实验室方法/溴甲酚紫实验室方法;调整后的优势比,0.60;95%置信区间,0.42至0.86)。由儿科肾病专家护理的患者血清钙水平显著更高,血清磷水平更低,完整甲状旁腺激素水平更低。
以成人为主的临床护理目标来看,在美国,儿科和IM肾病专家为接受血液透析的儿科患者提供的护理是相似的。然而,存在差异,这些差异的意义需要进一步研究。